欢迎来到创赛优选商城 !
Cy3-UTP(10mM) 抑胃肽酶液 PERFEMIKER AuroraGel 标准型基质胶,不含LDEV
光引发剂LAP 人工胃液 1%柠檬酸钠缓冲液 Salkowskis比色液 人工脑脊液(aCSF,无菌)
简介:NNC 55-0396是Mibefradil衍生物,是T型钙离子通道阻断剂。
NNC 55-0396物理化学性质:
沸点
713.8ºC at 760mmHg
分子式
C30H40Cl2FN3O2
分子量
564.562
闪点
385.5ºC
精确质量
563.248
PSA
58.22
LogP
7.6385
NNC 55-0396详细介绍:
中文名称:
1-溴-2-(二氟甲基)-4-氟苯
中文别名:
英文名称:
NNC 55-0396
英文别名:
Cyclopropanecarboxylicacid,(1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenylester, hydrochloride (1:2);(1S,2S)-2-[2-[[3-(1H-BENZIMIDAZOL-2-YL)PROPYL]METHYLAMINO]ETHYL]-6-FLUORO-1,2,3,4-TETRAHYDRO-1-(1-METHYLETHYL)-2-NAPHTHALENYL CYCLOPROPANECARBOXYLATE DIHYDROCHLORIDE;Cyclopropanecarboxylicacid,(1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-...;Cyclopropanecarboxylicacid,(1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-;NNC 55-0396 dihydrochloride;NNC 55-0396 dihydrochloride,(1S,2S)-2-[2-[[3-(1H-Benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenylcyclopropanecarboxylatedihydrochloride;NNC 55-0396
CAS号:
357400-13-6
分子式:
C30H38FN3O2.2CLH
分子量:
564.56
详细描述:
创赛优选提供357400-13-6,NNC 55-0396,Medlife,上海现货。
Medlife,致力于提供高品质、高性价比小分子化合物的产品。
Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。
T型钙离子通道阻断剂,NNC 55-0396是Mibefradil衍生物,是T型钙离子通道阻断剂。
查询关键词:“357400-13-6,NNC 55-0396,PC11878,Medlife,上海现货”。
NNC 55-0396参考文献:
[1]. Arnulfo Quesadaa, Peter H. Bui, Gregg E. Homanics,et al. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor. European Journal of Pharmacology. 2011,659 (1): 30-36.
[2]. Timo Strünker, Normann Goodwin, Christoph Brenker, et al. The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm. Nature, 2011,471, 382-386.
[3]. Hideto Miwa, Jinsoo Koh, Yoshinori Kajimoto, et al. Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats. Pharmacology Biochemistry and Behavior. 2011,97(4): 656-659.
[4]. Li M, Hansen JB, Huang L, et al. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. Cardiovasc Drug Rev. 2005 Summer;23(2):173-96.
[5]. Huang L, Keyser BM, Tagmose TM, et al. NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther. 2004 Apr;309(1):193-9.
创赛客服1
创赛客服2
创赛客服3
创赛客服4
400-608-7598